【白云山(00874.HK)附属广州医药拟通过增资扩股的方式引入战略投资者 预计募资10亿-30亿元】智通财经APP讯，白云山(00874.HK)公布，公司附属广州医药拟通过增资扩股的方式引入战略投资者。广州医药本次增资扩股发行股票不超过9.2亿股，预计募集资金总额在人民币10亿元(含10亿元)至30亿元(含30亿元)之间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.